Literature DB >> 16860606

Does off-pump coronary revascularization reduce the release of the cerebral markers, S-100beta and NSE?

Massimo Bonacchi1, Edvin Prifti, Massimo Maiani, Fabio Bartolozzi, Marco Di Eusanio, Marzia Leacche.   

Abstract

OBJECTIVES: The aims of this study were to (1) compare the release of S-100 beta and NSE in off-pump coronary artery bypass grafting (CABG) versus on-pump surgery; (2) investigate whether the S-100 beta and NSE serum concentrations correlate with cardiopulmonary bypass (CPB) duration.
MATERIALS AND METHODS: Between October 2002 and May 2004, 42 patients undergoing first time CABG surgery were enrolled in the study. The exclusion criteria were: LVEF<35%, age>70 years, previous myocardial infarction, REDO surgery, the presence of valvular heart disease and/or cerebrovascular disease, abnormal preoperative carotid vessels angiography, coronary artery disease involving the distal circumflex artery, renal dysfunction, coagulopathy. The patients were randomly assigned either to undergo on-pump CABG surgery [group I, n=24 patients] or off-pump CABG [group II, n=18 patients]. Blood was not re-transfused from the cardiotomy suction. All patients presenting haemolysis were excluded from the study.
RESULTS: The preoperative S-100beta was 0.13+/-0.08 (microg/l) and NSE 7+/-1.5 (microg/l) in group I and 0.12+/-0.1 (microg/l) and 6.9+/-2.7 (microg/l), respectively in group II. Six hours after the surgery, S-100beta in patients of group I reached a maximum level of 1.38+/-0.4 (microg/l) and NSE of 17.7+/-6.5 (microg/l) compared to 0.5+/-0.11 (microg/l) [S-100B] and NSE 8.6+/-4.2 (microg/l) in group II (p=0.001). Three (12%) patients in group I and none (0%) in group II suffered postoperative delirium, p=0.247. No strokes occurred linear regression analysis revealed a strong correlation between cardiopulmonary bypass duration and S-100beta and NSE peak levels, p<0.0021 (r(2)=0.36) and p<0.0001 (r=0.81), respectively.
CONCLUSION: Coronary artery bypass surgery with CPB causes a significantly greater increase in NSE and S-100beta serum levels than off-pump surgery and correlates with CPB duration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860606     DOI: 10.1016/j.hlc.2006.05.007

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  6 in total

1.  Risk factors for delirium after cardiac surgery: a historical cohort study outlining the influence of cardiopulmonary bypass.

Authors:  Jason B O'Neal; Frederic T Billings; Xulei Liu; Matthew S Shotwell; Yafen Liang; Ashish S Shah; Jesse M Ehrenfeld; Jonathan P Wanderer; Andrew D Shaw
Journal:  Can J Anaesth       Date:  2017-07-17       Impact factor: 5.063

2.  Comparison of S100B and NSE between cardiac surgery and interventional therapy for children.

Authors:  Yu Liu; Ying Xu; Da-zhen Li; Yuan Shi; Mao Ye
Journal:  Pediatr Cardiol       Date:  2009-05-27       Impact factor: 1.655

3.  Prevalence and risk factors of postoperative delirium in patients undergoing open heart surgery in northwest of iran.

Authors:  Ahmadreza Jodati; Nasser Safaie; Mohammadbagher Raoofi; Ladan Ghorbani; Fatemeh Ranjbar; Golamreza Noorazar; Majid Mosharkesh
Journal:  J Cardiovasc Thorac Res       Date:  2013-10-05

Review 4.  S100 and S100β: biomarkers of cerebral damage in cardiac surgery with or without the use of cardiopulmonary bypass.

Authors:  Shi-Min Yuan
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

5.  Serum S-100β and NSE levels after off-pump versus on-pump coronary artery bypass graft surgery.

Authors:  Lei Zheng; Qing-Ming Fan; Zhen-Yu Wei
Journal:  BMC Cardiovasc Disord       Date:  2015-07-16       Impact factor: 2.298

6.  The influence of carbon dioxide field flooding in mitral valve operations with cardiopulmonary bypass on S100ß level in blood plasma in the aging brain.

Authors:  Mariusz Listewnik; Katarzyna Kotfis; Paweł Ślozowski; Krzysztof Mokrzycki; Mirosław Brykczyński
Journal:  Clin Interv Aging       Date:  2018-09-25       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.